학술논문
Potent predictive CpG signature for temozolomide response in non-glioma-CpG island methylator phenotype glioblastomas with methylated MGMT promoter.
Document Type
Article
Author
Source
Epigenomics; Oct2022, Vol. 14 Issue 20, p1233-1247, 15p
Subject
Language
ISSN
17501911